Income Statement (TTM)
Carlsmed, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2023 12-31 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|
| Revenue | 14 | 27 | 32 | 38 |
| Change (%) | 97.16 | 18.79 | 18.60 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 4 | 7 | 8 | 10 |
| Change (%) | 83.66 | 15.89 | 20.55 | |
| % of Revenue | 28.12 | 26.20 | 25.56 | 25.98 |
| Gross Operating Profit | 10 | 20 | 24 | 28 |
| Change (%) | 102.44 | 19.81 | 17.93 | |
| % of Revenue | 71.88 | 73.80 | 74.44 | 74.02 |
| SG&A | 21 | 30 | 34 | 39 |
| Change (%) | 41.55 | 14.96 | 12.61 | |
| % of Revenue | 153.14 | 109.94 | 106.40 | 101.02 |
| R&D | 7 | 14 | 14 | 14 |
| Change (%) | 93.43 | -0.74 | 1.14 | |
| % of Revenue | 53.67 | 52.66 | 44.00 | 37.52 |
| OpEx | 32 | 51 | 57 | 63 |
| Change (%) | 58.44 | 10.71 | 10.89 | |
| % of Revenue | 234.93 | 188.80 | 175.96 | 164.53 |
| Operating Income | -19 | -24 | -25 | -25 |
| Change (%) | 29.75 | 1.62 | 0.75 | |
| % of Revenue | -134.93 | -88.80 | -75.96 | -64.53 |
| Interest Expense | -1 | -1 | -1 | -2 |
| Change (%) | 106.08 | 10.67 | 2.60 | |
| % of Revenue | -4.65 | -4.86 | -4.53 | -3.92 |
| Net Income | -19 | -24 | -25 | -25 |
| Change (%) | 28.36 | 1.16 | 1.99 | |
| % of Revenue | -137.16 | -89.30 | -76.05 | -65.40 |
Source: Capital IQ
